首页    期刊浏览 2024年12月06日 星期五
登录注册

文章基本信息

  • 标题:A steroid receptor coactivator stimulator (MCB-613) attenuates adverse remodeling after myocardial infarction
  • 本地全文:下载
  • 作者:Lisa K. Mullany ; Aarti D. Rohira ; John P. Leach
  • 期刊名称:Proceedings of the National Academy of Sciences
  • 印刷版ISSN:0027-8424
  • 电子版ISSN:1091-6490
  • 出版年度:2020
  • 卷号:117
  • 期号:49
  • 页码:31353-31364
  • DOI:10.1073/pnas.2011614117
  • 出版社:The National Academy of Sciences of the United States of America
  • 摘要:Progressive remodeling of the heart, resulting in cardiomyocyte (CM) loss and increased inflammation, fibrosis, and a progressive decrease in cardiac function, are hallmarks of myocardial infarction (MI)-induced heart failure. We show that MCB-613, a potent small molecule stimulator of steroid receptor coactivators (SRCs) attenuates pathological remodeling post-MI. MCB-613 decreases infarct size, apoptosis, hypertrophy, and fibrosis while maintaining significant cardiac function. MCB-613, when given within hours post MI, induces lasting protection from adverse remodeling concomitant with: 1) inhibition of macrophage inflammatory signaling and interleukin 1 (IL-1) signaling, which attenuates the acute inflammatory response, 2) attenuation of fibroblast differentiation, and 3) promotion of Tsc22d3-expressing macrophages—all of which may limit inflammatory damage. SRC stimulation with MCB-613 (and derivatives) is a potential therapeutic approach for inhibiting cardiac dysfunction after MI.
  • 关键词:myocardial infarction ; MCB-613 ; fibrosis
国家哲学社会科学文献中心版权所有